Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes.

MLA

Wang, Jian, et al. “Enhanced Doxorubicin Delivery to Hepatocellular Carcinoma Cells via CD147 Antibody-Conjugated Immunoliposomes.” Nanomedicine: Nanotechnology, Biology & Medicine, vol. 14, no. 6, Aug. 2018, pp. 1949–61. EBSCOhost, https://doi.org/10.1016/j.nano.2017.09.012.

APA

Wang, J., Wu, Z., Pan, G., Ni, J., Xie, F., Jiang, B., Wei, L., Gao, J., & Zhou, W. (2018). Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes. Nanomedicine: Nanotechnology, Biology & Medicine, 14(6), 1949–1961. https://doi.org/10.1016/j.nano.2017.09.012

Chicago

Wang, Jian, Zhitao Wu, Guoyu Pan, Junsheng Ni, Fangyuan Xie, Beige Jiang, Lixin Wei, Jie Gao, and Weiping Zhou. 2018. “Enhanced Doxorubicin Delivery to Hepatocellular Carcinoma Cells via CD147 Antibody-Conjugated Immunoliposomes.” Nanomedicine: Nanotechnology, Biology & Medicine 14 (6): 1949–61. doi:10.1016/j.nano.2017.09.012.